Admission high-sensitivity cardiac troponin levels as a prognostic indicator for in-hospital mortality rates in the elderly and very elderly COVID-19 patients
- PMID: 36156408
- PMCID: PMC9484855
- DOI: 10.1016/j.archger.2022.104822
Admission high-sensitivity cardiac troponin levels as a prognostic indicator for in-hospital mortality rates in the elderly and very elderly COVID-19 patients
Abstract
Background: Elevation of cardiac troponin (cTn) is associated with the worst prognosis not only in cardiovascular disease but also in non-cardiovascular disease. The aim of this study is to verify if cTn has a prognostic role in elderly and very elderly coronavirus disease 2019 (COVID-19) patients.
Methods: This study enrolled consecutive COVID-19 elderly patients hospitalized at INRCA hospital, with available admission high sensitivity cardiac troponin T (HS-cTnT) level. Patients were divided into three groups based on HS-cTnT level: group A (Hs-cTnT ≤ 40 pg/ml), group B (Hs-cTnT 41-100 pg/ml), and group C (Hs-cTnT ≥ 101 pg/ml). The correlation between HS-cTnT levels and mortality rates was analyzed.
Results: 461 patients (mean age 86 years; 59% female) were divided into group A (261 patients), group B (129 patients), and group C (71 patients). Group C resulted significantly older, more affected by heart failure, chronic obstructive pulmonary disease, chronic kidney disease, and dementia, and with higher levels of creatinine, C-reactive protein, pro-calcitonin, interleukin-6, ferritin, NT-proBNP, D-dimer then group A and group B. Mortality rate increased significantly across groups (group A: 18.4%; group B: 36.4%; group C: 62.0%; p<0.001). Group C had a significant increase in mortality risk compared to group A, both univariate analysis (HR 3.78) and multivariate analysis (model 2 HR 3.10; model 3 HR 3.59; model 4 HR 1.72).
Conclusion: HS-cTnT has demonstrated a prognostic role in elderly and very elderly COVID-19 patients. HS-cTnT is a simple and inexpensive laboratory exam that gives clinicians important information on mortality risk stratification.
Keywords: COVID-19; Elderly; High-sensitivity cardiac troponin assay; Mortality; SARSCov2; Troponin.
Copyright © 2022. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest None to declare
Figures
References
-
- Forman D.E., de Lemos J.A., Shaw L.J., Reuben D.B., Lyubarova R., Peterson E.D., Spertus J.A., Zieman S., Salive M.E., Rich M.W., et al. Cardiovascular biomarkers and imaging in older adults: JACC council perspectives. Journal of the American College of Cardiology. 2020;76:1577–1594. doi: 10.1016/j.jacc.2020.07.055. - DOI - PMC - PubMed
-
- Willeit P., Welsh P., Evans J.D.W., Tschiderer L., Boachie C., Jukema J.W., Ford I., Trompet S., Stott D.J., Kearney P.M., et al. High-sensitivity cardiac troponin concentration and risk of first-ever cardiovascular outcomes in 154,052 participants. Journal of the American College of Cardiology. 2017;70:558–568. doi: 10.1016/j.jacc.2017.05.062. - DOI - PMC - PubMed
-
- Sedighi S.M., Prud'Homme P., Ghachem A., Lepage S., Nguyen M., Fulop T., Khalil A. Increased level of high-sensitivity cardiac Troponin T in a geriatric population is determined by comorbidities compared to age. International Journal of Cardiology and Heart Vasc. 2019;22:187–191. doi: 10.1016/j.ijcha.2019.02.015. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials